SK
Sanjay Kumar Singh
About Sanjay Kumar Singh
Data last updated:
Sanjay Kumar Singh has 16 years in corporate governance. Holds Director role. Currently with 1 company, including Global Center For Gene Therapies Foundation and Lilac Lifesciences Private Limited. Formerly with 3 companies, such as Agati Healthcare Private Limited and Max Biomedix India Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 13 Jan 2025 | 2025 | – | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 31 Mar 2010 | 2010 | ₹3.73 Cr (FY 2024) | Active | |
| Director | 08 Jul 2010 | 2010 | – | Strike Off | |
| Director | 11 Nov 2009 | 2009 | – | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanjay Kumar Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanjay Kumar Singh
Sanjay Kumar Singh has 16 years in corporate governance. Holds Director role. Currently with 1 company, including Global Center For Gene Therapies Foundation and Lilac Lifesciences Private Limited. Formerly with 3 companies, such as Agati Healthcare Private Limited and Max Biomedix India Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Sanjay Kumar Singh is associated with 1 company as Director, including Global Center For Gene Therapies Foundation.
Sanjay Kumar Singh has expertise in General Business, Healthcare.
Sanjay Kumar Singh has 16 years in corporate governance.
Sanjay Kumar Singh currently holds positions at 1 company: Global Center For Gene Therapies Foundation.